Tetramer/BV421 - HLA-A*0201 PR-1 (VLQELNVTV)

Catalog No:
MBL-TS-0017-4
$1,575.00

Formerly Catalog No.: TB-0017-4

Description

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation BV421
Peptide Sequence VLQELNVTV
Class Class I
Sequence Location 169-177
MHC Allele A*02:01

Documents & Links

Documents & Links for Tetramer/BV421 - HLA-A*0201 PR-1 (VLQELNVTV)
Datasheet Tetramer/BV421 - HLA-A*0201 PR-1 (VLQELNVTV) Datasheet

Documents & Links for Tetramer/BV421 - HLA-A*0201 PR-1 (VLQELNVTV)
Datasheet Tetramer/BV421 - HLA-A*0201 PR-1 (VLQELNVTV) Datasheet

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation BV421
Peptide Sequence VLQELNVTV
Class Class I
Sequence Location 169-177
MHC Allele A*02:01

Documents & Links

Documents & Links for Tetramer/BV421 - HLA-A*0201 PR-1 (VLQELNVTV)
Datasheet Tetramer/BV421 - HLA-A*0201 PR-1 (VLQELNVTV) Datasheet

Documents & Links for Tetramer/BV421 - HLA-A*0201 PR-1 (VLQELNVTV)
Datasheet Tetramer/BV421 - HLA-A*0201 PR-1 (VLQELNVTV) Datasheet